Advisory Committee Disagreement With US FDA On Approval Decisions An Increasingly Rare Event

23 Jan 2023

A new study finds the agency only approved a product despite a negative advisory committee vote six times in six years. The overall rate of agreement between the agency and advisory committees has increased since 2015.

Agreement — FDA-advisory committee agreement was higher among priority applications compared to standard applications. • Source: Shutterstock

Advisory Committee Disagreement With US FDA On Approval Decisions An Increasingly Rare Event

More from US FDA Performance Tracker

More from Regulatory Trackers